Avapritinib Maintenance for AML With KIT Mutations
Clinical trial NCT06765915 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06765915
- Sponsor
- Ruijin Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-01
- Primary completion
- 2026-02-01
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.